Targeted Therapies for Pancreatic Cancer: Overview of Current Treatments and New Opportunities for Personalized Oncology

SIMPLE SUMMARY: The lack of early diagnosis and the absence of suitable biomarkers coupled with resistance to available therapeutic options render pancreatic cancer one of the deadliest cancer types. Therefore, new therapeutic approaches are needed to be developed, taking into account the genetic an...

Descripción completa

Detalles Bibliográficos
Autores principales: Leroux, Cédric, Konstantinidou, Georgia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918504/
https://www.ncbi.nlm.nih.gov/pubmed/33672917
http://dx.doi.org/10.3390/cancers13040799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918504/
https://www.ncbi.nlm.nih.gov/pubmed/33672917
http://dx.doi.org/10.3390/cancers13040799

Ejemplares similares